70. Spinal stenosis
91 clinical trials,   195 drugs   (DrugBank: 54 drugs),   60 drug target genes,   85 drug target pathways

Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03553186
(ClinicalTrials.gov)
July 11, 201829/5/2018Tranexamic Acid in Adult Spinal Deformity SurgeryTopical Tranexamic Acid as a Adjunct to Intravenous Tranexamic Acid in Adult Spinal Deformity SurgerySpinal Deformity;Degenerative Lumbar Spinal Stenosis;Blood Loss, SurgicalDrug: Tranexamic Acid 100 MG/ML;Drug: PlaceboHospital for Special Surgery, New YorkNULLRecruiting18 Years80 YearsAll100Phase 3United States
2NCT03011866
(ClinicalTrials.gov)
February 201716/12/2016Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine SurgeriesIntravenous Versus Topical Use of Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS) : A Prospective, Randomized, Double Blind, Head-to-head Comparison StudySpinal Stenosis;Intervertebral Disc DisplacementDrug: Wound topically irrigated with 500mg TXA;Drug: 1mg/kg/hr TXA intravenous infusion till the last suturePeking Union Medical College HospitalNULLNot yet recruiting50 YearsN/AAll176N/ANULL
3NCT02063035
(ClinicalTrials.gov)
August 201219/12/2013Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal SurgeryTopical Application of Tranexamic Acid to Reduce Postoperative Blood Loss in Posterior Approach Spinal SurgeryLumbar Spinal Stenosis;Thoracic Spinal StenosisDrug: Tranexamic Acid;Drug: PlaceboMassachusetts General HospitalNULLCompleted18 Years85 YearsAll29Phase 4United States